Company Filing History:
6 out of 580 
5 out of 3,381 
1 out of 1,217 
Years Active: 1990-2015
Title: Jiri Zemlicka: Innovator in Antiviral Compounds
Introduction
Jiri Zemlicka is a notable inventor based in Warren, MI (US). He has made significant contributions to the field of antiviral agents, holding a total of 9 patents. His work focuses on developing compounds that are effective against various viruses.
Latest Patents
Among his latest patents are the compounds 2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purines, which serve as antiviral agents. These compounds are designed to combat viral infections and include various formulas. Another significant patent involves 2,2-bis-(hydroxymethyl)cyclopropylidenemethyl-purines and -pyrimidines, which also act as antiviral agents. The purines in these compounds include well-known bases such as adenine, hypoxanthine, and guanine, among others. The pyrimidine components incorporate cytosine, uracil, and thymine, along with their derivatives.
Career Highlights
Jiri Zemlicka has worked at prestigious institutions such as Wayne State University and the University of Michigan. His research has focused on the development of innovative antiviral compounds, contributing to advancements in medical science.
Collaborations
Throughout his career, Zemlicka has collaborated with notable colleagues, including John Charles Drach and Yao-Ling Qiu. These partnerships have enhanced his research and expanded the impact of his inventions.
Conclusion
Jiri Zemlicka's work in the field of antiviral agents showcases his dedication to innovation and research. His contributions have the potential to significantly impact the treatment of viral infections.